Krishna Vaddi
2023
In 2023, Krishna Vaddi earned a total compensation of $2.6M as Chief Executive Officer at Prelude Therapeutics, a 20% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $330,625 |
|---|---|
| Option Awards | $1,735,873 |
| Salary | $572,667 |
| Other | $2,624 |
| Total | $2,641,789 |
Vaddi received $1.7M in option awards, accounting for 66% of the total pay in 2023.
Vaddi also received $330.6K in non-equity incentive plan, $572.7K in salary and $2.6K in other compensation.
Rankings
In 2023, Krishna Vaddi's compensation ranked 362nd out of 2,978 executives tracked by ExecPay. In other words, Vaddi earned more than 87.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 362 out of 2,978 | 88th |
Division Manufacturing | 207 out of 1,637 | 87th |
Major group Chemicals And Allied Products | 143 out of 906 | 84th |
Industry group Drugs | 140 out of 869 | 84th |
Industry Pharmaceutical Preparations | 86 out of 627 | 86th |
Source: SEC filing on April 26, 2024.
Vaddi's colleagues
We found two more compensation records of executives who worked with Krishna Vaddi at Prelude Therapeutics in 2023.